Neuromodulation for Post-Traumatic Stress Disorder

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 20, 2020

Study Completion Date

October 20, 2020

Conditions
Post-Traumatic Stress Disorder
Interventions
DEVICE

Trigeminal Nerve Stimulation

Subjects will be randomized to treatment with either active or sham TNS for a period of eight weeks. The programming will be set by an individual who has no contact with subjects to deliver TNS in a double-blind manner (n=37 in each group) at the active frequency of 120 Hz. TNS will be performed for approximately 8 hours each night, a protocol that subjects found acceptable in the pilot work.

DEVICE

Placebo

Subjects will be randomized to treatment with either active or sham TNS for a period of eight weeks. The programming will be set by an individual who has no contact with subjects to deliver TNS in a double-blind manner (n=37 in each group) at the sham frequency of 0 Hz. TNS will be performed for approximately 8 hours each night, a protocol that subjects found acceptable in the pilot work.

Trial Locations (1)

90073

VA PTSD Clinic, Los Angeles

All Listed Sponsors
collaborator

VA Greater Los Angeles Healthcare System

FED

collaborator

United States Department of Defense

FED

lead

University of California, Los Angeles

OTHER

NCT02377089 - Neuromodulation for Post-Traumatic Stress Disorder | Biotech Hunter | Biotech Hunter